Dhanvantri Jeevan Rekha Ltd.
| BSE: 531043 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE239F01015 |
| BSE 00:00 | 17 Jan | 20.83 |
0.99 (4.99%) |
OPEN
20.83 |
HIGH
20.83 |
LOW
20.83 |
| NSE 05:30 | 01 Jan | Dhanvantri Jeevan Rekha Ltd |
| OPEN | 20.83 |
| PREVIOUS CLOSE | 19.84 |
| VOLUME | 8855 |
| 52-Week high | 20.83 |
| 52-Week low | 5.83 |
| P/E | 21.70 |
| Mkt Cap.(Rs cr) | 9 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dhanvantri Jeevan Rekha Ltd. (DHANVANTRIJEEV) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 685.70 | -9.45 | -1.36 | 15823.68 |
| Cipla | 910.50 | -10.90 | -1.18 | 13900.58 |
| Dr Reddy's Labs | 4673.60 | -14.60 | -0.31 | 13349.10 |
| Sun Pharma.Inds. | 853.20 | -7.05 | -0.82 | 12803.21 |
| Lupin | 942.55 | -9.85 | -1.03 | 11055.93 |
| Apollo Hospitals | 4911.50 | -62.55 | -1.26 | 9153.00 |
| Cadila Health. | 438.05 | -4.10 | -0.93 | 7790.40 |
| Glenmark Pharma. | 516.70 | 0.70 | 0.14 | 7567.93 |
| Alkem Lab | 3576.50 | -45.75 | -1.26 | 7219.68 |
| Divi's Lab. | 4629.25 | 13.80 | 0.30 | 6798.61 |
| Torrent Pharma. | 3187.30 | -3.00 | -0.09 | 6450.83 |
| Ipca Labs. | 1063.75 | 0.80 | 0.08 | 5114.11 |
| Alembic Pharma | 798.60 | -4.15 | -0.52 | 5051.44 |
| Laurus Labs | 507.65 | -13.30 | -2.55 | 4768.72 |
| Abbott India | 17530.45 | -167.80 | -0.95 | 4310.02 |
| Gland Pharma | 3694.15 | -32.50 | -0.87 | 3462.88 |
| Glaxosmi. Pharma | 1738.15 | -24.80 | -1.41 | 3193.74 |
| Granules India | 331.15 | -26.65 | -7.45 | 3134.98 |
| Sanofi India | 7514.75 | -66.35 | -0.88 | 2901.90 |
| Ajanta Pharma | 2306.80 | 0.05 | 0.00 | 2718.59 |
Quick Links for Dhanvantri Jeevan Rekha:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
